Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomasPeter Martin, John P. Leonard, Scott Ely et al.|Leukemia & lymphoma/Leukemia and lymphoma|2015Cited by 49
Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with<sup>131</sup>I-tositumomabRebecca Elstrom, Mark Kaminski, Jia Ruan et al.|Leukemia & lymphoma/Leukemia and lymphoma|2014Cited by 14